We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Brain Radiotherapy May Not Be Necessary for Patients with Lung Cancer Metastases

By MedImaging International staff writers
Posted on 13 Sep 2016
Print article
Image: The image displays an example of Hippocampal-sparing whole brain radiotherapy (Photo courtesy of ResearchGate).
Image: The image displays an example of Hippocampal-sparing whole brain radiotherapy (Photo courtesy of ResearchGate).
The results of a phase 3 randomized trial have revealed that there was no beneficial effect in terms of survival rate or quality of life, for patients who underwent whole brain radiotherapy, compared to those who received only steroid treatment and supportive care.

The results indicate that patients suffering from a common form of lung cancer, with brain metastases may not need to undergo whole brain radiotherapy that can result in substantial harmful side effects such as nausea, fatigue and neurotoxicity.

The research was published in the August 2016 online edition of the journal The Lancet. The researchers found that whole brain radiotherapy could be beneficial in patients below the age of 60, but should not be used for standard treatment of most patients suffering from Non-Small Cell Lung Cancer (NSCLC) with brain metastases.

According to the researchers 11% of the participants randomized to whole-brain radiotherapy were too ill or died before they could receive the treatment. The assessment of quality-of-life was also limited, in order not to overburden the seriously ill patients.

Study author, Dr Paula Mulvenna, consultant clinical oncologist at the Newcastle Hospitals NHS Foundation Trust (Newcastle upon Tyne, UK), said, "Whole brain radiotherapy was widely adopted into clinical practice based on the assumption it improves tumor control in patients with brain metastases. But in our lung cancer clinics, we were not seeing the improvements we had hoped for in our patients. Survival times are poor and have hardly changed since the 1980s. What's more, the technique's toxicity can be substantial and it can damage cognitive function."

Related Links:
Newcastle Hospitals NHS Foundation Trust

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Brachytherapy Planning System
Oncentra Brachy
New
Portable Radiology System
DRAGON ELITE & CLASSIC
New
Color Doppler Ultrasound System
KC20

Print article

Channels

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The Cinematic Reality app enables interaction with realistic renderings of human anatomy (Photo courtesy of Siemens)

AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning

Siemens Healthineers (Erlangen, Germany) has launched an app designed for Apple Vision Pro that allows users including surgeons, medical students, or patients to view immersive, interactive holograms of... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.